Key result
Cell-free mitochondrial DNA levels increased 16-fold at the end of cardiopulmonary bypass compared to baseline (472 to 7722 copies/µL) and showed a trend toward association with post-operative complications.
Why the study?
Post-operative complications remain a challenge after surgical AVR, and inflammation caused by increased release of cell-free mitochondrial DNA during surgery may be a contributing factor.
Does cell-free mitochondrial DNA predict the risk of post-operative complications in adult patients undergoing surgical aortic valve replacement with cardiopulmonary bypass?
Observational (n=24)
No
Does cell-free mitochondrial DNA predict the risk of post-operative complications in adult patients undergoing surgical aortic valve replacement with cardiopulmonary bypass?
Cell-free mitochondrial DNA levels increase significantly during surgical aortic valve replacement with cardiopulmonary bypass and may serve as an early biomarker for predicting post-operative complications.
Cf-mtDNA trends with post-CPB complications; hypothesis-generating for biomarker validation before any clinical adoption.
Surgical aortic valve replacement (AVR) is the standard of care for severe aortic valve disease; however, post-operative complications continue to pose challenges. Inflammation caused by increased release of cell-free mitochondrial DNA (cf-mtDNA) during surgery may be a contributing factor. The aim of this pilot study was to investigate the relationship between cf-mtDNA release and the risk of inflammatory-mediated post-operative complications in adult AVR patients. Plasma was collected from patients undergoing an AVR with cardiopulmonary bypass (CPB) at baseline, intra-operatively and post ICU admission at 6, 12 and 18 h. Cf-mtDNA was quantified and inflammatory biomarker expression in leukocytes and plasma was assessed. Cf-mtDNA levels increased 16-fold at the end of CPB with a corresponding increase in average fragment size. Cf-mtDNA levels may be associated with post-operative bleeding, infection, hepatic failure and hospital length of stay. Gene expression and plasma analysis revealed altered levels of markers associated with inflammation and innate immune responses. Several markers were associated with post-operative complications and outcomes. Our results indicate that cf-mtDNA levels, including average fragment sizes, are increased following initiation of CPB in AVR patients, and may be associated with post-operative complications and outcomes. However, larger studies are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Hyslop et al. (2025) conducted an observational in Severe aortic valve disease (n=24). Cell-free mitochondrial DNA (cf-mtDNA) release vs. Baseline levels was evaluated on cf-mtDNA levels at the end of cardiopulmonary bypass (p=<0.001). Cell-free mitochondrial DNA levels increased 16-fold at the end of cardiopulmonary bypass compared to baseline (472 to 7722 copies/µL) and showed a trend toward association with post-operative complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: